Pharmacodynamics. the plant components that make up the preparation bronchipret tp have secretolytic and antispasmodic properties.
Saponins from primrose roots exhibit a secretolytic effect, which is achieved mainly by a reflex mechanism due to irritation of the sensitive nerve endings of the vagus nerve of the digestive tract.
Essential oils and flavonoids of thyme herb have bronchospasmolytic and secretolytic effects. The antibacterial effect of the preparation was also confirmed, due to the thymol component of the essential oil from the herb of thyme.
Pharmacokinetics. The thymol component of thyme essential oil is excreted mainly by the lungs. Flavonoids (eg apigenin, luteolin) of thyme herbs are broken down by the intestinal microflora and are well absorbed into the bloodstream and excreted either unchanged or as metabolites, mainly by the kidneys.
Treatment of acute and inflammatory diseases of the respiratory tract, accompanied by a cough with the formation of viscous sputum.
Adults and children over 12 years of age take 1 tablet 3 times a day.
The tablets should be taken without chewing, with a sufficient amount of liquid (mainly a glass of water) before meals.
The duration of treatment depends on the course of the disease. Usually the course of treatment is 1 week. If long-term treatment is necessary, the patient should consult a doctor. See also information in the SPECIAL INSTRUCTIONS and SIDE EFFECTS sections.
Increased individual sensitivity to the components of the preparation, as well as to other types of primroses or other medicinal plants of the labiate family, to birch, wormwood and celery.
Gastrointestinal disturbances, including cramps, nausea, vomiting, and diarrhea, are uncommon. very rarely, hypersensitivity reactions are possible, including difficulty breathing, skin rashes, itching, hives, swelling of the face, mouth and / or pharynx.
In case of any adverse reactions, you should stop using the preparation and consult a doctor.
If an allergic reaction occurs, Bronchipret TP tablets must not be reused.
Due to the content of glucose and lactose, the preparation should not be taken by patients with hereditary galactose intolerance, lactase deficiency or glucose-galactose malabsorption.
If symptoms persist for more than 1 week or difficulty breathing, fever, purulent or bloody sputum, the patient should see a doctor immediately.
Patients with gastritis or stomach ulcers should not use Bronchipret TP film-coated tablets without consulting a doctor.
Note for diabetics. 1 tablet contains an average of 0.02 XE. The tablets are gluten free.
Pregnancy. Due to the lack of data on the use of the preparationshould not be used during pregnancy and lactation.
Fertility There is no data on the effect of the preparationon the female ability to reproduce offspring. In experimental studies, no effect on fertility was observed.
Children. Due to the lack of safety studies, the preparationshould not be used in children under 12 years of age.
The ability to influence the reaction rate when driving or working with other mechanisms. Does not affect.
Not marked. use in combination with antibacterial preparations is possible.
Possible stomach upset, vomiting and diarrhea. symptomatic treatment.
In its original packaging at a temperature not exceeding 25 ° c.